임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
42건 표시
- 4상모집 중단 (진행 중)· Focal Onset SeizureOpen-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy
리드: SK바이오팜
- 1/2상조기 종료· Advanced Solid TumorSafety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients
리드: SK바이오팜
- 3상모집 중단 (진행 중)· Partial EpilepsySafety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures
리드: SK바이오팜
- 1상완료· Hepatic ImpairmentSafety Study of Cenobamate in Subjects With Normal Hepatic Function and Subjects With Severe Hepatic Impairment
리드: SK바이오팜
- 1상완료· Partial EpilepsyDose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures
리드: SK바이오팜
- 3상완료· Partial SeizureRandomized, Double-blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in POS
리드: SK바이오팜
- 3상완료· Primary Generalized Tonic Clonic Seizures in the Setting of Idiopathic Generalized EpilepsyCenobamate Open-Label Extension Study for YKP3089C025
리드: SK바이오팜
- 1상완료· Lennox Gastaut SyndromeCarisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome
리드: SK바이오팜
- 1상완료· Lennox Gastaut SyndromeCarisbamate in Adult & Pediatric Subjects With Lennox-Gastaut Syndrome
리드: SK바이오팜
- 3상완료· Primary Generalized EpilepsyRandomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures
리드: SK바이오팜
- 1상완료· Healthy VolunteerA Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users
리드: SK바이오팜
- 3상완료· Partial EpilepsySafety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
리드: SK바이오팜
- 2상완료· Chronic ConstipationA Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation
리드: SK바이오팜
- 2상완료· Painful Diabetic NeuropathyA Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
리드: SK바이오팜
- 2상완료· Partial EpilepsyEfficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures
리드: SK바이오팜
- 2상완료· Diabetic NeuropathiesAn Efficacy and Safety Study of Carisbamate in the Treatment of Nerve Pain in Diabetics
리드: SK바이오팜
- 3상완료· Epilepsy, Partial, MotorAn Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures
리드: SK바이오팜
- 3상완료· Epilepsy, Partial, MotorA Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.
리드: SK바이오팜
- 2상완료· Essential Tremor, Movement DisordersA Proof of Concept Study of the Effectiveness of Carisbamate in the Treatment of Essential Tremor
리드: SK바이오팜
- 2상완료· Postherpetic NeuralgiaAn Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN).
리드: SK바이오팜
- 2상완료· Diabetic Neuropathy, PainfulStudy for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN).
리드: SK바이오팜
- 2상완료· Refractory EpilepsySafety and Efficacy of 333369 in the Treatment of Partial Epilepsy
리드: SK바이오팜
- 2상완료· Migraine HeadachesA Study of the Efficacy of RWJ-333369 in the Prevention of Migraine
리드: SK바이오팜
- 단계 미표기상태 미확인· Partial Epilepsy세노바메이트 확대접근 프로그램(EAP)
Cenobamate Expanded Access Program (EAP)
리드: SK바이오팜
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.